Kintegral Advisory
GILD icon

Kintegral Advisory’s Gilead Sciences GILD Stock Holding History

Kintegral Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.3M Buy
115,751
+654
+0.6% +$91.8K 1.36% 10
2026
Q2 		$14.5M Hold
115,097
– – 1.18% 16
2026
Q1 		$16M Sell
115,097
-5,103
-4% -$715K 1.52% 7
2025
Q4 		$14.8M Sell
120,200
-3,290
-3% -$400K 1.25% 12
2025
Q3 		$13.7M Sell
123,490
-552
-0.4% -$62.7K 1.17% 13
2025
Q2 		$13.8M Sell
124,042
-187
-0.2% -$19.9K 1.25% 10
2025
Q1 		$13.9M Sell
124,229
-417
-0.3% -$43K 1.4% 8
2024
Q4 		$11.5M Sell
124,646
-5,807
-4% -$523K 1.09% 16
2024
Q3 		$10.9M Sell
130,453
-1,709
-1% -$130K 1% 17
2024
Q2 		$9.07M Buy
132,162
+51,403
+64% +$3.43M 0.87% 22
2024
Q1 		$5.92M Sell
80,759
-252
-0.3% -$19.4K 0.59% 43
2023
Q4 		$6.56M Sell
81,011
-516
-0.6% -$40.2K 0.73% 35
2023
Q3 		$6.11M Sell
81,527
-48
-0.1% -$3.69K 0.75% 30
2023
Q2 		$6.29M Hold
81,575
– – 0.74% 32
2023
Q1 		$6.77M Sell
81,575
-4,383
-5% -$363K 0.87% 25
2022
Q4 		$7.38M Buy
85,958
+38,996
+83% +$3.09M 0.98% 21
2022
Q3 		$2.9M Hold
46,962
– – 0.4% 69
2022
Q2 		$2.9M Buy
46,962
+994
+2% +$61.5K 0.38% 67
2022
Q1 		$2.73M Buy
45,968
+1,028
+2% +$65.7K 0.3% 83
2021
Q4 		$3.26M Hold
44,940
– – 0.34% 69
2021
Q3 		$3.14M Hold
44,940
– – 0.37% 65
2021
Q2 		$3.1M Hold
44,940
– – 0.37% 64
2021
Q1 		$2.9M Hold
44,940
– – 0.37% 70
2020
Q4 		$2.62M Hold
44,940
– – 0.36% 70
2020
Q3 		$2.84M Sell
44,940
-1,446
-3% -$100K 0.43% 63
2020
Q2 		$3.57M Hold
46,386
– – 0.57% 41
2020
Q1 		$3.47M Buy
46,386
+5,189
+13% +$359K 0.68% 38
2019
Q4 		$2.68M Hold
41,197
– – 0.49% 56
2019
Q3 		$2.61M Hold
41,197
– – 0.52% 48
2019
Q2 		$2.78M Hold
41,197
– – 0.56% 46
2019
Q1 		$2.68M Buy
41,197
+27,349
+197% +$1.82M 0.56% 43
2018
Q4 		$866K Buy
+13,848
New +$968K 0.26% 91

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Kintegral Advisory's GILD Position: Q3 2026 in Review

Kintegral Advisory increased its Gilead Sciences (GILD) stake by 0.57% in Q3 2026, buying an estimated $91.8K and bringing the position to 115,751 shares worth $17.3M. The position accounts for 1.36% of the portfolio, ranked #10.

Kintegral Advisory first reported a position in GILD in Q4 2018 and has held it in 32 quarters since. 664 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Kintegral Advisory held 115,751 shares of Gilead Sciences worth $17.3M as of Q3 2026.
  • Kintegral Advisory bought 654 Gilead Sciences shares in Q3 2026, an estimated $91.8K.
  • Gilead Sciences made up 1.36% of Kintegral Advisory's portfolio in Q3 2026, its #10 holding.
  • Kintegral Advisory first reported a position in Gilead Sciences in Q4 2018 and has held it in 32 quarters since.
  • 664 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Kintegral Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.